KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Twist Bioscience (TWST) Accumulated Depreciation & Amortization (2018 - 2026)

Twist Bioscience has reported Accumulated Depreciation & Amortization over the past 9 years, most recently at $6.4 million for Q1 2026.

  • Quarterly Accumulated Depreciation & Amortization changed 0.19% to $6.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.4 million through Mar 2026, changed 0.19% year-over-year, with the annual reading at $24.9 million for FY2025, 20.93% down from the prior year.
  • Accumulated Depreciation & Amortization was $6.4 million for Q1 2026 at Twist Bioscience, up from $6.2 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $31.4 million in Q3 2024 and troughed at $5.3 million in Q4 2022.
  • The 5-year median for Accumulated Depreciation & Amortization is $12.3 million (2023), against an average of $14.9 million.
  • Year-over-year, Accumulated Depreciation & Amortization skyrocketed 79.99% in 2023 and then crashed 61.14% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $5.3 million in 2022, then soared by 54.4% to $8.2 million in 2023, then dropped by 21.92% to $6.4 million in 2024, then fell by 2.92% to $6.2 million in 2025, then rose by 3.55% to $6.4 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Accumulated Depreciation & Amortization are $6.4 million (Q1 2026), $6.2 million (Q4 2025), and $24.9 million (Q3 2025).